Auditory and Vestibular Ringing--Detection and theraputic interventions. Tinnitus effects up to 30% of the elderly population. To date no single suppression modality has been successful across all tinnitus sufferers. This study will apply an aural, low level, modulated, fractal suppression strategy designed to induce a "natural" olivary efferent response capable of suppressing/reducing tinnitus.
Balance disorders e.g. Meniere's Disease and nausea (seasickness) are unwanted outcomes of vestibu ....Auditory and Vestibular Ringing--Detection and theraputic interventions. Tinnitus effects up to 30% of the elderly population. To date no single suppression modality has been successful across all tinnitus sufferers. This study will apply an aural, low level, modulated, fractal suppression strategy designed to induce a "natural" olivary efferent response capable of suppressing/reducing tinnitus.
Balance disorders e.g. Meniere's Disease and nausea (seasickness) are unwanted outcomes of vestibular dysfunction/hypersensitivity. This study will apply a low level, low frequency, modulated, acoustic pressure wave designed to induce a ?natural? olivary efferent response and an end organ endolymph/perilymph balance shift. It is postulated these stimuli will reduce the effects of vestibular dysfunction/hypersensitivity.
Read moreRead less
Using the eye as a window to the central nervous system for improved drug testing. The annual cost of treating brain illnesses is US$250 billion. Each new drug costs about US$900 million to develop. This research will give Pfizer Pty Ltd, the project’s industry partner, a more efficient and direct way of testing whether drugs can get into and affect the brain. This will reduce the cost of drug development, which ultimately means cheaper drugs. The project will develop new technologies to put Aus ....Using the eye as a window to the central nervous system for improved drug testing. The annual cost of treating brain illnesses is US$250 billion. Each new drug costs about US$900 million to develop. This research will give Pfizer Pty Ltd, the project’s industry partner, a more efficient and direct way of testing whether drugs can get into and affect the brain. This will reduce the cost of drug development, which ultimately means cheaper drugs. The project will develop new technologies to put Australia at the forefront of neuropharmaceutical and neuroscience research. A new research platform will foster collaborations with the pharmaceutical industry both within Australia and overseas. This industrial link will promote a unique post-graduate experience by providing exposure to academic and industrial environments for Australian scientists.Read moreRead less